SARS-CoV-2 induced Coronavirus Disease 19 (COVD-19), a highly transmissible and potentially lethal illness, became a global pandemic in early 2020. Several vaccinations against this virus have been developed, including 2 novel...
Read MoreFor a study, the researchers sought to see if early serum neurofilament light (sNfL) and glial fibrillary acidic protein (sGFAP) levels, assessed at baseline and 1 year later, provide predictive value to models of commonly...
Read MorePatients with severe multiple sclerosis (MS) were increasingly receiving autologous hematopoietic stem cell transplantation (aHSCT). For a study, the researchers sought to look at the short and long-term results after aHSCT in...
Read MoreIn patients with multiple sclerosis (MS), cognitive dysfunction particularly slowed cognitive processing speed (CPS), was a key source of disability. Compared to intramuscular interferon (IFN) Beta-1a, the sphingosine...
Read More
Among the disruptions in timely medical care caused by the COVID-19 pandemic is the receipt of...
Read More
The use of the FDA-approved checkpoint inhibitor pembrolizumab in clinical practice—for previously...
Read More
The toxicity observed with full doses of lenvatinib and the underrepresentation of Black...
Read More
The standard of care following gynecologic oncology surgery may include post-discharge calls to...
Read More
To determine whether sentinel lymph node mapping (SLN) in patients with endometrial hyperplasia is...
Read More
With prior research indicating that self-hypnosis (SH) may help reduce preoperative distress and...
Read MoreThis year’s Kenneth P. Johnson Memorial Lecturer is Ruth Ann Marrie, MD, PhD, FRCPC. ACTRIMS presents an annual lecture named in honor of the late Dr. Kenneth P. Johnson who founded the foundation. The lecture provides an...
Read MoreThe Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) hosted the seventh annual forum, February 24-26. This year’s forum was themed Biomarkers in MS. Highlights of the forum include the Kenneth...
Read MoreThe Society of Gynecologic Oncology (SGO) 2022 Annual Meeting on Women’s Cancer is a comprehensive forum for the subspecialty of gynecologic oncology. Because of the continuing pandemic, the annual meeting will be hybrid taking...
Read MoreOperate and Optimize: Enhancing Perioperative Quality, Safety, Experience and Outcomes Friday, March 18, 8:00 a.m. to 12:00 p.m. MST Moderators: Rebecca Stone, MD, MS, and Sean Dowdy, MD Rare but Revelatory: Clinical Updates and...
Read MoreJ. Nwando Olayiwola, MD, MPH, FAAFP American Board of Obstetrics and Gynecology Guest Lecturer Friday, March 18, 2:15 p.m. – 3:00 p.m. MST Reshma Jagsi, MD, DPhil Gender Equity Session: Together We Stand, Divided We Fall...
Read MoreFriday, March 18th: 7:00 AM – 12:30 PM Debulk and Deliver: Hands-On Cytoreductive Surgery Lab 8:00 AM – 12:00 PM Master Class: Rare but Revelatory: Clinical Updates & Research Advancements in Uncommon Gynecologic...
Read MoreA significant drop in the screening, diagnosis and treatment of genitourinary cancers was observed during the early months of the COVID-19 pandemic. Hereafter, a progressive recovery was observed. Notably, the screening rate for...
Read More
An ongoing open-label, randomized phase 3 trial (NCT04736706) will determine the efficacy of the...
Read MoreResults from the ATLANTIS trial platform indicate that rucaparib could play a role in the maintenance treatment of metastatic urothelial carcinoma with a DNA repair deficiency that has responded to first-line platinum-based...
Read More
Updated data from the KEYNOTE-564 trial shows pembrolizumab disease-free survival persists long...
Read More
